These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5560869)

  • 1. Multiple myeloma in spouses.
    Kyle RA; Heath CW; Carbone P
    Arch Intern Med; 1971 May; 127(5):944-6. PubMed ID: 5560869
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of malignant disease metastatic to bone by hormonal alterations.
    Mellette SJ
    Clin Orthop Relat Res; 1970; 73():73-88. PubMed ID: 5479779
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytogenetic studies in monoclonic gammapathies].
    Zakharova AV; Mokeeva RA
    Probl Gematol Pereliv Krovi; 1971 Sep; 16(9):13-22. PubMed ID: 5125878
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow changes following chemotherapy for multiple myeloma--a clinicopathological study of biopsy cases.
    Kurihara K; Hill W; Burkhardt R; Kettner G; Hashimoto N
    Nihon Ketsueki Gakkai Zasshi; 1987 Jul; 50(4):876-89. PubMed ID: 3687331
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multiple myeloma].
    Wasastjerna C
    Duodecim; 1974; 90(10):751-64. PubMed ID: 4605799
    [No Abstract]   [Full Text] [Related]  

  • 6. [Medical treatment of multiple myeloma].
    Astaldi G; Meardi G; Yalçin B
    Cancro; 1973; 26(5):319-37. PubMed ID: 4793834
    [No Abstract]   [Full Text] [Related]  

  • 7. Significance of bone marrow fibrosis in multiple myeloma.
    Subramanian R; Basu D; Dutta TK
    Pathology; 2007 Oct; 39(5):512-5. PubMed ID: 17886102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases.
    Body JJ; Greipp P; Coleman RE; Facon T; Geurs F; Fermand JP; Harousseau JL; Lipton A; Mariette X; Williams CD; Nakanishi A; Holloway D; Martin SW; Dunstan CR; Bekker PJ
    Cancer; 2003 Feb; 97(3 Suppl):887-92. PubMed ID: 12548591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cyclic use of multiple alkylating agents in multiple myeloma.
    Harley JB; Ramanan SV; Kim I; Thiagarajan PV; Chen JH; Gomez R; Koppel D; Hyde F; Gustke S; Krall J
    W V Med J; 1972 Jan; 68(1):1-3. PubMed ID: 4500402
    [No Abstract]   [Full Text] [Related]  

  • 10. [Smoldering multiple myeloma].
    Zapatero A; Blanco L; Sevilla F; Fraile G; Montalbán C
    Rev Clin Esp; 1985 May; 176(9):469-70. PubMed ID: 4023335
    [No Abstract]   [Full Text] [Related]  

  • 11. Melphalan and dexamethasone for patients with multiple myeloma who are not candidates for autologous stem cell transplantation.
    Sharma A; Lokeshwar N; Raina V; Mohanti BK; Kumar R
    Natl Med J India; 2007; 20(3):121-4. PubMed ID: 17867615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin and chromosome abnormalities in multiple myeloma.
    Rosenberg EB; Liu CH; Yang SL; Wang CH; Hwang TS
    Taiwan Yi Xue Hui Za Zhi; 1970 Aug; 69(8):399-404. PubMed ID: 4098498
    [No Abstract]   [Full Text] [Related]  

  • 13. A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma.
    Dasanu CA; Alexandrescu DT
    Eur J Haematol; 2009 Mar; 82(3):231-4. PubMed ID: 19018868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relapse of multiple myeloma in extramedullary sites].
    Bairey O; Huminer D; Blickstein D; Sandbank Y; Shaklai M
    Harefuah; 1993 May; 124(9):539-41, 600. PubMed ID: 8340001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bortezomib-induced Sweet syndrome.
    Knoops L; Jacquemain A; Tennstedt D; Theate I; Ferrant A; Van den Neste E
    Br J Haematol; 2005 Oct; 131(2):142. PubMed ID: 16197442
    [No Abstract]   [Full Text] [Related]  

  • 16. [Multiple myeloma manifesting as cardiac insufficiency].
    Bennis A; Niang A; Lebbar K; Nafidi S; Zaid D; Tahiri A; Chraibi N
    Ann Med Interne (Paris); 1999 Feb; 150(2):160-1. PubMed ID: 10392265
    [No Abstract]   [Full Text] [Related]  

  • 17. Newer treatment options for patients in first relapse. From the Multiple Myeloma Research Foundation.
    Richardson P
    Oncology (Williston Park); 2006 May; 20(6):633-8. PubMed ID: 16773847
    [No Abstract]   [Full Text] [Related]  

  • 18. Aclarubicin in the treatment of multiple myeloma.
    Sezaki T; Adachi T; Ishii H; Asano K; Takahashi I; Kimura I
    Jpn J Clin Oncol; 1984 Sep; 14(3):353-8. PubMed ID: 6384577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone disease.
    Heider U; Hofbauer LC; Zavrski I; Kaiser M; Jakob C; Sezer O
    Biochem Biophys Res Commun; 2005 Dec; 338(2):687-93. PubMed ID: 16216218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of blood protein disorders].
    Wuhrmann F
    Clin Ter; 1970 May; 53(4):291-8. PubMed ID: 4990207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.